Syensqo (SYENS) investor relations material

Executive summary

• Achieved 5% year-over-year organic sales growth in Q2 2026, led by Materials, with Composite Materials up 18% and Specialty Polymers returning to growth.

• Gross profit rose 7% year-over-year to €528 million, with gross margin expanding to 34%.

• Underlying EBITDA was €311 million, down 6% year-over-year but up 24% sequentially, with margin at 20%.

• Operating cash flow increased significantly to €131 million, driven by the absence of separation costs and positive working capital effects.

• Strategic review of the Performance & Care segment initiated, with advisors appointed to maximize shareholder value and align with a focus on specialty materials and advanced technologies.

Financial highlights

• Net sales for Q2 2026 were €1.55 billion, up 4–5% year-over-year and 11% sequentially.

• Gross profit margin improved by 100 basis points year-over-year to 34%.

• Underlying EBITDA margin at 20%, down 220 basis points year-over-year.

• Operating cash flow for Q2 was €131 million, up significantly year-over-year; capital expenditures decreased 16% to €95 million.

• Net income attributable to shareholders was €106 million; basic EPS was €1.04, down 24% year-over-year.

Outlook and guidance

• Full-year 2026 underlying EBITDA outlook raised to at least €1.1 billion, up from previous guidance.

• Operating cash flow guidance unchanged at approximately €700 million; capital expenditure guidance at €450 million.

• Anticipates low to mid-single digit volume growth for the full year, supported by improved order book in Materials.

• Q3 EBITDA expected to be broadly in line with Q2, with continued caution due to geopolitical uncertainty.